Teladoc Health (TDOC) Current Deferred Revenue (2019 - 2026)

Teladoc Health's Current Deferred Revenue history runs 8 years deep, the most recent figure standing at $65.7 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 21.94% year-over-year to $65.7 million; the TTM figure through Mar 2026 stood at $65.7 million (down 21.94% YoY), while the FY2025 annual figure was $62.3 million, down 30.06% from the prior year.
• Current Deferred Revenue came in at $65.7 million for Q1 2026 at Teladoc Health, up from $62.3 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $121.6 million in Q2 2023 to a low of $62.3 million in Q4 2025.
• A 5-year average of $97.2 million and a median of $107.2 million in 2024 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue surged 50.55% in 2022 and tumbled 30.31% in 2025, its largest moves.
• Teladoc Health's Current Deferred Revenue stood at $113.8 million in 2022, then fell by 3.96% to $109.3 million in 2023, then fell by 18.48% to $89.1 million in 2024, then tumbled by 30.06% to $62.3 million in 2025, then climbed by 5.47% to $65.7 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $65.7 million, $62.3 million, and $70.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison